 The standards regarding pharmaceutical products are determined and modified by the "Pharmacopeia Council".As of 2019, Iran says it produces 80-90% of the raw materials needed inside the country.These include microplates, omeprazole, tamsulosin hydrochloride, naltrexone base, sitagliptin phosphate, and pioglitazone in various sizes.